NFKB1 and neoplasm: Furthermore, emerging evidence indicates that transcriptional regulators and stress-responsive pathways such as NF-κB 17, 18 Hypoxia-inducible factors (HIFs) 19, and nuclear receptors 20 contribute to resistance by promoting tumor cell adaptation to chemotherapy-induced stress 21.